82 related articles for article (PubMed ID: 20835743)
1. Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in rats.
Noda T; Abe F; Ueyama J; Kato M; Katoh M; Nadai M; Saito H; Hasegawa T
J Infect Chemother; 2011 Apr; 17(2):207-13. PubMed ID: 20835743
[TBL] [Abstract][Full Text] [Related]
2. Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats.
Abe F; Ueyama J; Kimata A; Kato M; Hayashi T; Nadai M; Saito H; Takeyama N; Noguchi H; Hasegawa T
Life Sci; 2008 Aug; 83(7-8):229-35. PubMed ID: 18638490
[TBL] [Abstract][Full Text] [Related]
3. In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats.
Yanni SB; Augustijns PF; Benjamin DK; Brouwer KL; Thakker DR; Annaert PP
Drug Metab Dispos; 2010 Oct; 38(10):1848-56. PubMed ID: 20606004
[TBL] [Abstract][Full Text] [Related]
4. Role of plasma proteins in pharmacokinetics of micafungin, an antifungal antibiotic, in analbuminemic rats.
Abe F; Ueyama J; Kawasumi N; Nadai M; Hayashi T; Kato M; Ohnishi M; Saito H; Takeyama N; Hasegawa T
Antimicrob Agents Chemother; 2008 Sep; 52(9):3454-6. PubMed ID: 18591270
[TBL] [Abstract][Full Text] [Related]
5. Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding.
Yanni SB; Smith PB; Benjamin DK; Augustijns PF; Thakker DR; Annaert PP
Biopharm Drug Dispos; 2011 May; 32(4):222-32. PubMed ID: 21449041
[TBL] [Abstract][Full Text] [Related]
6. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
[TBL] [Abstract][Full Text] [Related]
7. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats.
Ando H; Nishio Y; Ito K; Nakao A; Wang L; Zhao YL; Kitaichi K; Takagi K; Hasegawa T
Antimicrob Agents Chemother; 2001 Dec; 45(12):3462-7. PubMed ID: 11709325
[TBL] [Abstract][Full Text] [Related]
8. Effect of blood decrease on micafungin disposition in rats.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Yamaji A
Eur J Drug Metab Pharmacokinet; 2011 Mar; 36(1):35-9. PubMed ID: 21350921
[TBL] [Abstract][Full Text] [Related]
9. Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Takada K; Yamaji A
Fundam Clin Pharmacol; 2010 Aug; 24(4):457-62. PubMed ID: 19845766
[TBL] [Abstract][Full Text] [Related]
10. Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats.
Suzuki T; Zhao YL; Nadai M; Naruhashi K; Shimizu A; Takagi K; Takagi K; Hasegawa T
Life Sci; 2006 Jun; 79(5):455-61. PubMed ID: 16483613
[TBL] [Abstract][Full Text] [Related]
11. Saturation of multidrug-resistant protein 2 (mrp2/abcc2)-mediated hepatobiliary secretion: nonlinear pharmacokinetics of a heterocyclic compound in rats after intravenous bolus administration.
Hu Y; Sampson KE; Heyde BR; Mandrell KM; Li N; Zutshi A; Lai Y
Drug Metab Dispos; 2009 Apr; 37(4):841-6. PubMed ID: 19139164
[TBL] [Abstract][Full Text] [Related]
12. Prediction of in vivo biliary clearance from the in vitro transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II monolayer expressing both rat organic anion transporting polypeptide 4 and multidrug resistance associated protein 2.
Sasaki M; Suzuki H; Aoki J; Ito K; Meier PJ; Sugiyama Y
Mol Pharmacol; 2004 Sep; 66(3):450-9. PubMed ID: 15322236
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and safety profiles of repeated-dose prophylactic micafungin in children and adolescents undergoing hematopoietic stem cell transplantation.
Albano E; Azie N; Roy M; Townsend R; Arrieta A
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e45-50. PubMed ID: 25072363
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of micafungin in subjects with severe hepatic dysfunction.
Undre N; Pretorius B; Stevenson P
Eur J Drug Metab Pharmacokinet; 2015 Sep; 40(3):285-93. PubMed ID: 24888485
[TBL] [Abstract][Full Text] [Related]
15. Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury.
Li X; Zhong K; Guo Z; Zhong D; Chen X
Drug Metab Dispos; 2015 Nov; 43(11):1751-9. PubMed ID: 26276582
[TBL] [Abstract][Full Text] [Related]
16. Hepatic contribution to a marked increase in the plasma concentration of baicalin after oral administration of its aglycone, baicalein, in multidrug resistance-associated protein 2-deficient rat.
Akao T; Sato K; Hanada M
Biol Pharm Bull; 2009 Dec; 32(12):2079-82. PubMed ID: 19952434
[TBL] [Abstract][Full Text] [Related]
17. Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2.
Hidemura K; Zhao YL; Ito K; Nakao A; Tatsumi Y; Kanazawa H; Takagi K; Ohta M; Hasegawa T
Antimicrob Agents Chemother; 2003 May; 47(5):1636-42. PubMed ID: 12709333
[TBL] [Abstract][Full Text] [Related]
18. Intraocular penetration of micafungin in patient with Candida albicans endophthalmitis.
Mochizuki K; Suemori S; Udo K; Komori S; Ohkusu K; Yamada N; Ogura S
J Ocul Pharmacol Ther; 2011 Oct; 27(5):531-3. PubMed ID: 21751880
[TBL] [Abstract][Full Text] [Related]
19. Circadian Clock Is Involved in Regulation of Hepatobiliary Transport Mediated by Multidrug Resistance-Associated Protein 2.
Oh JH; Lee JH; Han DH; Cho S; Lee YJ
J Pharm Sci; 2017 Sep; 106(9):2491-2498. PubMed ID: 28479363
[TBL] [Abstract][Full Text] [Related]
20. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
